title: Factors associated with early reinduction chemotherapy for adults with acute myeloid leukemia.
authors.affiliation: Department of Medicine, University of Washington , Seattle, WA , USA.
authors.forename: Masumi
authors.initials: M
authors.lastname: Ueda
authors.forename: Hu
authors.initials: H
authors.lastname: Xie
authors.forename: Ravinder K
authors.initials: RK
authors.lastname: Sandhu
authors.forename: Roland B
authors.initials: RB
authors.lastname: Walter
authors.forename: John M
authors.initials: JM
authors.lastname: Pagel
authors.forename: Elihu H
authors.initials: EH
authors.lastname: Estey
mesh_terms: D000208:Acute Disease; D000328:Adult; D000368:Aged; D000971:Antineoplastic Combined Chemotherapy Protocols / Q000627:therapeutic use*; D001856:Bone Marrow Examination; D002452:Cell Count; D003561:Cytarabine / Q000008:administration & dosage / Q000627:therapeutic use*; D006801:Humans; D060828:Induction Chemotherapy / Q000379:methods*; D007951:Leukemia, Myeloid / Q000188:drug therapy* / Q000473:pathology; D008875:Middle Aged; D014411:Neoplastic Stem Cells / Q000187:drug effects / Q000473:pathology; D012074:Remission Induction; D019233:Retreatment; D013997:Time Factors
chemical_list: D003561:Cytarabine